THE DIAGNOSIS OF DRUG TOXIDERMIA BY THE METHOD OF STIMULATED BARIUM SULFATE LUMINOL-DEPENDENT CHEMILUMINESCENCE OF LEUKOCYTES


Cite item

Full Text

Abstract

Objective. the determination of ibuprofen, paracetamol, nimesulide, amoxicillin, ceftriaxone effect on barium sulfate-stimulated luminol-dependent chemiluminescence of leukocytes (SLHL) in patients with drug toxidermy, which occurred after taking these drugs, and the control group for the selection of the drug for replacement therapy. Material and methods. there were 67 patients (44 women and 23 men) with drug toxidemia. 22.4% patients had drug toxidermia after taking ibuprofen, 20.9% patients had drug toxidermia after taking paracetamol, 19.4% patients had drug toxidermia after taking nimesulide, 20.9% patients had drug toxidermia after taking amoxicillin, 16.4% patients had drug toxidermia after taking ceftriaxone and a control group consisting of 67 people (42 women and 25 men), who previously took these drugs without any adverse reactions. The study participants were aged 18 to 75 years, median 53. Measurement SLHL of leukocytes was performed on the Lum-100 chemiluminometer. The calculations were carried out using the computer program «PowerGraph». Results. during the influence of ibuprofen, paracetamol, nimesulide, amoxicillin, ceftriaxone on the blood of patients with intolerance to these drugs and the control group dose-dependent changes in SLHL were observed. The relative intensity and light sum of blood SLHL in patients were significantly lower than in the control group at all studied drug concentrations (p < 0.01). The relative intensity and light sum of blood SLHL in patients were significantly lower in samples with the drug that caused the development of the disease than with drugs for replacement therapy (p < 0.01). At a minimum concentration of these drugs, there are no significant differences between these indicators (p > 0.05). Conclusion. During the influence of ibuprofen, paracetamol, nimesulide, amoxicillin, ceftriaxone on the blood of patients with intolerance to these drugs and the control group, a dose-dependent change in SLHL is observed. The relative intensity and light sum of SLHL blood in patients are significantly lower than that of the control group at all studied concentrations of the drug (p < 0.01). The relative intensity and light sum of blood SLHL in patients were significantly lower in samples with the drug, which caused the development of the disease, in the maximum concentration than with drugs for replacement therapy (p < 0.01). In the minimum concentration, there were no significant differences in indicators (p > 0.05). The revealed significant differences in SLHL indices allow applying the chemiluminescent method for the diagnosis of intolerance to ibuprofen, paracetamol, nimesulide, amoxicillin, ceftriaxone and for a personalized selection of drugs for replacement therapy.

About the authors

N. P Teplyuk

Department of Dermatology and Venereology, I. M. Sechenov First Moscow State Medical University (Sechenov University)

Moscow, 119435, Russian Federation

N. L Shimanovskiy

Department of Molecular Pharmacology and Radiobiology of Pirogov Russian National Research Medical University

Moscow, 119435, Russian Federation

A. V Semeykin

Department of Molecular Pharmacology and Radiobiology of Pirogov Russian National Research Medical University

Moscow, 119435, Russian Federation

Zilola S. Kadyrova

Department of Dermatology and Venereology, I. M. Sechenov First Moscow State Medical University (Sechenov University)

Email: rose1604@yandex.ru
postgraduate of Department of Dermatology and Venereology of I.M. Sechenov First Moscow State Medical University, Moscow, 119991, Russian Federation Moscow, 119435, Russian Federation

References

  1. Олисова О.Ю., ред. Кожные и венерические болезни: Учебник. М.: Практическая медицина; 2015: 149-51.
  2. Файзуллина Е.В., Давыдов Ю.В. Лекарственная токсикодермия: лечение и профилактика. Практическая медицина. 2013; (1): 9-12.
  3. Чаусова С.В., Бондарева Г.П., Усанова Е.А. Влияние диклофенака натрия на оксидантные функции полиморфно-ядерных лейкоцитов периферической крови здоровых доноров и больных с повышенной чувствительностью к диклофенаку. Медицинский вестник Башкортостана. 2014; 9(1): 73-6.
  4. Чаусова С.В., Гуревич К.Г., Усанова Е.А., Арутюнова У.Э., Балякин Ю.В., Малышев И.Ю. Влияние нестероидных противовоспалительных препаратов на хемилюминесценцию полиморфно-ядерных лейкоцитов у пациентов с непереносимостью данных препаратов. Экспериментальная и клиническая фармакология. 2014; 77(5): 28-31.
  5. Czech W., Barbisch M., Tenscher K., Schopf E., Schroder J.M., Norgauer J. Chemotactic 5-oxo-eicosatetraenoic acidsinduce oxygen radical production, Ca2+-mobilization, and actin reorganization in human eosinophils via a pertussis toxin-sensitive G-protein. J. Invest. Dermatol. 1997; 108(1): 108-12.
  6. Чаусова С.В. Особенности оксидантной активности фагоцитов периферической крови больных с непереносимостью нестероидных противовоспалительных препаратов и обоснование патогенетической терапии непереносимости нестероидных противовоспалительных препаратов: Автореф. дис. … д-ра мед. наук: Москва; 2016: 3-6.
  7. Теплюк Н.П., Кадырова З.С. Разнообразие клинических проявлений лекарственной токсидермии у больных, находившихся на лечении в клинике кожных и венерических болезней им. В.А. Рахманова ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава Росии. Современные проблемы науки и образования. 2019; 3. Доступно на: http://science-education.ru/ru/article/view?id=28900 (28.02.2020).
  8. Бизунок Н.А. Влияние противовоспалительных средств на фагоцитарную генерацию оксидантов. Белорусский медицинский журнал. 2002; 2: 56-8.
  9. Dona I., Blanca-Lopez N., Torres M.J., Garcia-Campos J., Garcia Nunez I., Gomez F., et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J. Investig. Allergol. Clin. Immunol. 2012; 22(5): 363-71.
  10. Dai H.F., Wang X.W., Zhao K. Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis. Hepatobiliary Pacreat. Dis. Int. 2009; 8(1): 11-6.
  11. Lee Q.U. Hypersensitivity to antipyretics: pathogenesis, diagnosis, and management. Hong Kong Med. J. 2017; 23(4): 395-403.
  12. Takayama F., Egashira T., Yamanaka Y. Effect of diclofenak, a nonsteroidal anti-inflammatory drug, on lipid peroxidation caused by ischemia-reperfusion in rat liver. Jap. J. Pharmacol. 1994; 64(1): 71-8.
  13. Bhattacharya S. The facts about penicillin allergy: a review. J. Adv. Pharm. Technol. Res. 2010; 1(1): 11-7.
  14. Cornego-Garcia J.A., Jurado-Escobar R., Dona I., Blanca M. The genetics of drug hypersensitivity reactions. J. Invest. Allergol. Clin. Immunol. 2016; 26(4): 222-32.
  15. Pham D.L., Kim J.H., Trinh T.H., Park H.S. What we know about nonsteroidal anti-inflammatory drug hypersensitivity. Korean J. Intern. Med. 2016; 31(3): 417-32.

Copyright (c) 2019 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies